In addition, overexpression of NEFL increases the chemosensitivity of glioma cells to TMZ treatment by downregulating the multidrug resistance factors ABCG2, ABCC3, and ABCC5, which are ABC transporters and function as xenobiotic transporters. This evidence concerns the gene ABCG2 and glioma.